86.90.E - Healthcare
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
68.20.Z - Rental and management of own or leased real estate
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 3,3 | 1,7 | 2,2 | 32,9 |
Gross profit (loss) | 3,6 | 2,1 | 2,4 | 17,2 |
EBITDA | 3,8 | 2,4 | 2,8 | 16,1 |
Short time liabilities | 1,5 | 2 | 2,2 | 12,4 |
Other operating costs | 0 | 0 | 0 | 43,8 |
Equity capital | 3,6 | 5,7 | 8,1 | 42,3 |
Operating profit (EBIT) | 3,6 | 2,2 | 2,4 | 11,3 |
Assets | 5,8 | 9,7 | 11 | 14,1 |
Net profit (loss) | 2,9 | 2 | 2,4 | 18,6 |
Cash | 3,1 | 2,6 | 3,8 | 47,2 |
Liabilities and provisions for liabilities | 2,1 | 4 | 3 | -25,9 |
Net income from sale | 14,5 | 14,1 | 17,7 | 25,2 |
Working assets | 4 | 3,8 | 5,3 | 39 |
Other income costs | 0,3 | 0,5 | 0,2 | -57,6 |
Depreciation | 0,3 | 0,2 | 0,4 | 60,3 |
% | % | % | p.p. | |
Profitability of capital | 80,1 | 35,7 | 29,7 | -6 |
Equity capital to total assets | 63,2 | 58,7 | 73,2 | 14,5 |
Gross profit margin | 24,7 | 14,6 | 13,7 | -0,9 |
EBITDA Margin | 26,5 | 17 | 15,7 | -1,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 39 | 51 | 46 | -5 |
Current financial liquidity indicator | 2.5661017894744873 | 1.9405170679092407 | 2.399264335632324 | 0,5 |
Net dept to EBITDA | -0.5969823002815247 | -0.10730471462011337 | -1.0017603635787964 | -0,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane